Topical non-steroidal anti-inflammatory drugs in allergic conjunctivitis: Meta-analysis of randomized trial data

Ophthalmic Epidemiology

Volumn 14, Issue 5, 2007, Pages 311-319

  Swamy, Brighu N ^a   Chilov, Michael ^a   McClellan, Kathy ^a   Petsoglou, Con ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Allergic Conjunctivitis; Meta Analysis; Placebo; Systematic Review; Topical NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; BETAMETHASONE; DICLOFENAC; FLURBIPROFEN; HYDROCORTISONE; KETOROLAC; LEVOCABASTINE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PLACEBO;

ALLERGIC CONJUNCTIVITIS; ARTICLE; BURNING SENSATION; CHEMOSIS; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFECT; DRUG EFFICACY; EYE PAIN; EYELID; HUMAN; META ANALYSIS; OCULAR PRURITUS; PHOTOPHOBIA; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SWELLING; SYSTEMATIC REVIEW;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CONJUNCTIVITIS, ALLERGIC; HUMANS; PRURITUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 36249026314     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580701299411     Document Type: Article

References (29)

1. Calonge M. Classification of ocular atopic/allergic disorders and conditions: An unsolved problem. Acta Ophthalmol Scand Suppl. 1999; 228:10-13.
2. Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmol. 2003; 217(2):89-98.
3. Uchio E. Possibility of non-steroidal treatment in allergic conjunctival diseases. Allerg Internat. 2004; 53(4):315-319.
4. Helleboid L. Treatment of allergic conjunctivitis and keratoconjunctivitis summary. Revue Francaise d'Allergologie et d'Immunologie Clinique 2004; 44(1):71-75.
5. Hingorani M, Lightman S. Therapeutic options in ocular allergic disease. Drugs. 1995; 50(2):208-221.
6. Bielory L. Ocular allergy guidelines: a practical treatment algorithm. Drugs. 2002; 62(11):1611-1634.
7. Al Yusuf NSH, Al Alawi EK. The effect of diclofenac sodium on allergic conjunctivitis. J Bahrain Med Soc.1999; 11(2):26-31.
8. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients:A clinical and immunocytochemical study.[see comment]. Am J Ophthalmol. 2003; 136(4):593-602.
9. D'Angelo G, Lambiase A, Cortes M, Sgrulletta R, Pasqualetti R, Lamagna A, Bonini S. Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis. Graefes Arch Clin Exper Ophthalmol. 2003; 241(3):192-195.
10. Deschenes J, Discepola M, Abelson M. Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model. Acta OphthalmolScandSuppl. 1999; 228:47-52.
11. Discepola M, Deschenes J, Abelson M. Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis. Acta Ophthalmol ScandiSuppl. 1999; 228:43-46.
12. James IG, Campbell LM, Harrison JM, Fell PJ, Ellers-Lenz B, Petzold U. Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhinoconjunctivitis. Curr Med Res Opin. 2003; 19(4):313-320.
13. Leonardi A, Busato F, Fregona I, Plebani M, Secchi AG. Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model. Br J Ophthalmol. 2000; 84(11):1228-1232.
14. Miyake-Kashima M, Takano Y, Tanaka M, Satake Y, Kawakita T, Dogru M, Asano-Kato N, Fukagawa K, Fujishima H. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis. Japan J Ophthalmol. 2004; 48(6):587-590.
15. Notivol R, Martinez M, Bergamini MV. Treatment of chronic nonbacterial conjunctivitis with a cyclo-oxygenase inhibitor or a corticosteroid. Pranoprofen Study Group. Am J Ophthalmol. 1994; 117(5):651-656.
16. Shulman DG, Amdahl L, Washington C, Graves A. A combined analysis of two studies assessing the ocular comfort of antiallergy ophthalmic agents. Clin Therapeut. 2003; 25(4):1096-1106.
17. Tauber J, Raizman MB, Ostrov CS, Laibovitz RA, Abelson MB, Betts JG, Koester JM, Gill D, Schaich L. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. J Ocular Pharmacol Therapeu. 1998; 14(2):137-145.
18. Ciprandi G, Cerqueti PM, Sacca S, Ciurlo G, Tosca MA, Canonica GW. Non-steroidal treatment of pollen-induced conjunctivitis: Comparison of different pharmacological protocols. Allergy 1991; 46(5):393-395.
19. Ballas Z, Blumenthal M, Tinkelman DG, Kriz R, Rupp G. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol. 1993; 38 Suppl:141-148. .
20. Donshik PC, Pearlman D, Pinnas J, Raizman MB, Tauber J, Tinkelman D, Walters TR. Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis. Adv Ther. 2000; 17(2):94-102.
21. Laibovitz RA, Koester J, Schaich L, Reaves TA. Safety and effi-cacy of diclofenac sodium 0.1% ophthalmic solution in acute seasonal allergic conjunctivitis. J Ocul Pharmacol Therapeu. 1995; 11(3):361-368.
22. Sharma A, Gupta R, Ram J, Gupta A. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis. Indian J Ophthalmol. 1997; 45(3):177-180.
23. Sud RN, Greval RS, Bajwa RS. Topical flurbiprofen therapy in vernal keratoconjunctivitis. Indian J Med Sci. 1995; 49(9):205-209.
24. Tinkelman DG, Rupp G, Kaufman H, Pugely J, Schultz N. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol. 1993; 38 Suppl:133-140.
25. Yaylali V, Demirlenk I, Tatlipinar S, Ozbay D, Esme A, Yildirim C, Ozden S. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis. Acta Ophthalmol Scand.2003; 81(4):378-382.
26. Ciprandi G, Buscaglia S, Cerqueti MP, Sacca S, Tosca M, Canonica GW. Topical anti-inflammatory drugs in the treatment of allergic pollinosic conjunctivitis: a comparative double-blind study. J InvestigationAllergology Clinl Immunol. 1992; 2(5):248-252.
27. Sharir M. Exacerbation of asthma by topical diclofenac. Arch Ophthalmol. 1997; 115(2):294-295.
28. Sheehan GJ, Kutzner MR, Chin WD. Acute asthma attack due to ophthalmic indomethacin. Ann InternMed. 1989; 111(4):337-338.
29. Uchio E, Kadonosono K. Acute asthma attack caused by ophthalmic application of antiallergic agents. Japan J Ophthalmol. 2004; 48(5):475-477.